Moving Forward in Human Mammary Stem Cell Biology and Breast Cancer Prognostication Using ALDH1
- 1 November 2007
- journal article
- editorial
- Published by Elsevier in Cell Stem Cell
- Vol. 1 (5) , 485-487
- https://doi.org/10.1016/j.stem.2007.10.015
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Mesenchymal stem cells within tumour stroma promote breast cancer metastasisNature, 2007
- The Activity of Class I, II, III, and IV of Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase in Pancreatic CancerPancreas, 2007
- Susceptibility to lung cancer and genetic polymorphisms in the alcohol metabolite‐related enzymes alcohol dehydrogenase 3, aldehyde dehydrogenase 2, and cytochrome P450 2E1 in the Japanese populationCancer, 2007
- SP analysis may be used to identify cancer stem cell populationsExperimental Cell Research, 2006
- Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cellsProceedings of the National Academy of Sciences, 2006
- Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activityBlood, 2004
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003